4CPS-013 Effect of 2 mg intravenous phytonadione treatment on international normalised ratio in the hospitalised adult by Ramon, N, Rosado Ancin, M, Santaolalla Sanchez, A, Valdazo Martin, C, Larrabeiti Echevarria, A, Garcia Albás, JJ, Hernanz Chaves, R, Martinez, C

Get full text

4CPS-303 Efficacy and safety of monotherapy with pembrolizumab in non-microcytic metastatic lung cancer in clinical practice by Valdazo Martín, C, García Albás, JJ, Moralejo, MÁ Andrés, Poyo Molina, J, Ramon Rigau, N, Rosado Ancín, M, Santaolalla Sánchez, A, Arenales Cáceres, P, Hernanz Chaves, R, Guisasola Ron, L, Martínez Martínez, C

Get full text

4CPS-335 Experience in the use of tocilizumab in patients with COVID-19. Has it really been effective? by Valdazo Martín, C, Ramon Rigau, N, Rosado Ancín, M, Urrestarazu Larrañaga, M, Santaolalla Sánchez, A, Hernanz Chaves, R, García Albás, JJ, Gómez Ugartondo, E, Guisasola Ron, L, Arenales Cáceres, P, Martínez Martínez, C

Get full text

4CPS-104 Switching oral antiandrogenic treatment in patients with castrate metastatic prostate cancer: an analysis by Valdazo Martín, C, García Albás, JJ, Moralejo, MÁ Andrés, Ayerra Pérez, H, Rosado Ancín, M, Santaolalla Sánchez, A, Ramón Rigau, N, Larrabeiti Echevarria, A, Martínez Martínez, C

Get full text